Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 6924637, 6 pages
https://doi.org/10.1155/2017/6924637
Research Article

Fulminant Type 1 Diabetes in Children: A Multicenter Study in China

1National Key Discipline of Pediatrics, Department of Endocrinology, Genetics and Metabolism, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China
2Department of Microbiology and Immunology, Dartmouth College, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
3Department of Endocrinology, Children’s Hospital of Shanghai, Shanghai Jiao Tong University, Shanghai 200062, China
4Department of Endocrinology and Genetic Metabolism, Zhengzhou Children’s Hospital, Zhengzhou 450053, China
5Department of Endocrinology, Children’s Hospital of Soochow University, Suzhou 215003, China
6Department of Endocrinology, Nanjing Children’s Hospital of Nanjing Medical University, Nanjing 210005, China
7Department of Endocrinology, Genetics and Metabolism, The Children’s Hospital of Guiyang City, Guiyang 550003, China
8Department of Pediatric, Liaocheng Children’s Hospital, Shandong 252002, China
9The Pediatric Endocrine Department, Chengdu Woman and Children’s Center Hospital, Chengdu 610091, China
10Department of Pediatric, General Hospital of Ningxia Medical University, Yinchuan 750004, China

Correspondence should be addressed to Chunxiu Gong; moc.anis@gnoguixnuhc

Received 30 December 2016; Revised 18 April 2017; Accepted 17 May 2017; Published 26 September 2017

Academic Editor: Ruozhi Zhao

Copyright © 2017 Yi Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Imagawa, T. Hanafusa, J. Miyagawa, and Y. Matsuzawa, “A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetesrelated antibodies. Osaka IDDM Study Group,” The New England Journal of Medicine, vol. 342, no. 5, pp. 301–307, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Kawasaki, T. Maruyama, A. Imagawa et al., “Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the committee of Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus,” Journal of Diabetes Investigation, vol. 5, no. 1, pp. 115–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Imagawa and T. Hanafusa, “Fulminant type 1 diabetes-an import subtype in East Asia,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 8, pp. 959–964, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Napartivaummuay, T. Suthornthepvarakul, C. Deerochanawong, V. Sarinnapakorn, and S. Niramitmahapanya, “Fulminant type 1 diabetes: the first case report in Thailand,” Journal of the Medical Association of Thailand, vol. 96, Supplement 3, pp. s114–s117, 2013. View at Google Scholar
  5. T. S. Jung, S. I. Chung, M. A. Kim et al., “A Korean patient with fulminant autoantibody-negative type 1 diabetes,” Diabetes Care, vol. 27, pp. 3023-3024, 2004. View at Google Scholar
  6. Y. M. Cho, J. T. Kim, K. S. Ko et al., “Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes,” Diabetologia, vol. 50, pp. 2276–2279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. H. Kim, H. Y. Kim, J. A. Seo et al., “A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan,” Diabetes Research and Clinical Practice, vol. 86, pp. e43–e45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Kim, C. J. Kim, C. W. Ko, P. H. Hwang, and D. Y. Lee, “Fulminant type 1 diabetes mellitus in Korean adolescents,” Journal of Pediatric Endocrinology & Metabolism, vol. 24, no. 9-10, pp. 679–681, 2011. View at Google Scholar
  9. C. Zheng, Z. Zhou, L. Yang et al., “Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese,” Diabetes/Metabolism Research and Reviews, vol. 27, pp. 70–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Moreau, D. Drui, G. Arnault-Ouary, B. Charbonnel, L. Chaillous, and B. Cariou, “Fulminant type 1 diabetes in Caucasians: a report of three cases,” Diabetes & Metabolism, vol. 34, pp. 529–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. McCauley and X. Wang, “Fulminant type 1 diabetes mellitus-like presentation in a Hispanic woman in the United States,” Diabetes & Metabolism, vol. 37, pp. 356–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Imagawa, T. Hanafusa, Y. Uchigata et al., “Fulminant type 1 diabetes-a nationwide survey in Japan,” Diabetes Care, vol. 26, pp. 2345–2352, 2003. View at Google Scholar
  13. S. Luo, Z. Zhang, X. Li et al., “Fulminant type 1 diabetes: a collaborative clinical cases investigation in China,” Acta Diabetologica, vol. 50, pp. 53–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Mallone, E. Martinuzzi, P. Blancou et al., “CD8+ T-cell responses identify cell autoimmunity in human type 1 diabetes,” Diabetes, vol. 56, no. 3, pp. 613–621, 2007. View at Google Scholar
  15. A. Shimada, J. Morimoto, K. Kodama et al., “T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes,” Diabetes Care, vol. 25, no. 3, pp. 635-636, 2002. View at Google Scholar
  16. A. Shimada, Y. Oilawa, T. Shigihara, T. Senda, and K. Kodama, “A case of fulminant type 1 diabetes with strong evidence of autoimmunity,” Diabetes Care, vol. 25, no. 3, pp. 1482-1483, 2002. View at Google Scholar
  17. R. Kotani, M. Nagata, A. Imagawa et al., “T lymphocyte response against pancreatic beta cell antigens in fulminant type 1 diabetes,” Diabetologia, vol. 47, no. 7, pp. 1285–1291, 2004. View at Publisher · View at Google Scholar
  18. K. Katsumata and K. Katsumata, “A Chinese patient presenting with clinical signs of fulminant type 1 diabetes mellitus,” Internal Medicine, vol. 44, no. 9, pp. 967–969, 2005. View at Google Scholar
  19. T. Iwaoka, “A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies,” Endocrine Journal, vol. 50, no. 2, pp. 225–231, 2003. View at Google Scholar
  20. Z. Wang, Y. Zheng, Y. Tu, Z. Dai, J. Lin, and Z. Zhou, “Immunological aspects of fulminant type 1 diabetes in Chinese,” Journal of Immunology Research, vol. 2016, Article ID 1858202, 6 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Martin, D. Wolf-Eichbanm, G. Duinkerken et al., “Development of type 1 diabetes despite severe hereditary B-cell deficiency,” The New England Journal of Medicine, vol. 345, no. 14, pp. 1036–1040, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. B. O. Roep, “The role of T-cells in the pathogenensis of type 1 diabetes: from cause to cure,” Diabetologia, vol. 46, no. 3, pp. 305–321, 2003. View at Publisher · View at Google Scholar
  23. T. Nakamura, S. Nagasaka, I. Kusaka, T. Yatagai, J. Yang, and S. Ishibashi, “HLA-DR-DQ haplotype in rapid-onset type 1 diabetes in Japanese,” Diabetes Care, vol. 26, no. 5, pp. 1640-1641, 2003. View at Google Scholar
  24. S. Murao, H. Makino, Y. Kaino et al., “Differences in the contribution of HLA-DR and DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients,” Diabetes, vol. 53, no. 10, pp. 2684–2690, 2004. View at Google Scholar
  25. C. Tsutsumi, A. Imagawa, H. Ikegami et al., “Class II HLA genotype in fulminant type 1 diabetes: a nationwide survey with reference to glutamic acid decarboxylase antibodies,” Journal of Diabetes Investigation, vol. 3, no. 1, pp. 62–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. Kwak, Y. J. Kim, J. Chae et al., “Association of HLA genotype and fulminant type 1 diabetes in Koreans,” Genomics & Informatics, vol. 13, no. 4, pp. 126–131, 2015. View at Publisher · View at Google Scholar
  27. T. Nishiumi, K. Okamoto, S. Inamoto et al., “Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection,” Journal of Diabetes Investigation, vol. 5, no. 4, pp. 472-473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Ohara, M. Kaneko, T. Nishibori et al., “Fulminant type 1 diabetes mellitus associated with Coxsackie virus type A2 infection: a case report and literature review,” Internal Medicine, vol. 55, no. 6, pp. 643–646, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Nishida, K. Aida, M. Kihara, and T. Kobayashi, “Antibody-validated proteins in inflamed islets of fulminant type 1 diabetes profiled by laser-capture microdissection followed by mass spectrometry,” PLoS One, vol. 9, no. 10, article e107664, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Tanaka, T. Koboyashi, and T. Mototsu, “A novel subtype of type 1 diabetes mellitus,” The New England Journal of Medicine, vol. 342, pp. 1835–1183, 2000. View at Google Scholar
  31. K. Aida, Y. Nishida, S. Tanaka et al., “RIG-I– and MDA5-initiated innate immunity linked with adaptive immunity accelerates b-cell death in fulminant type 1 diabetes,” Diabetes, vol. 60, pp. 884–889, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Aida, S. Saitoh, Y. Nishida et al., “Distinct cell clusters touching islet cells induce islet cell replication in association with over-expression of regenerating gene (REG) protein in fulminant type 1 diabetes,” PLoS One, vol. 9, no. 8, article e105449, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Yamashita, Y. Sato, K. Seki et al., “Fulminant type 1 diabetes with robust recovery of insulin secretion: a case report,” Diabetes Research and Clinical Practice, vol. 100, no. 2, pp. e34–e38, 2013. View at Publisher · View at Google Scholar · View at Scopus